61.   Dr. Richard Borison and Bruce Diamond were longtime favorites of pharmaceutical companies developing schizophrenia drugs.

62.   Drug companies have long sought to develop drugs that take advantage of tumor suppressor genes because such drugs might work in a wide variety of cancers.

63.   DuPont Merck Pharmaceutical Co., said it formed a three-year venture with Signal Pharmaceuticals Inc. to research and develop antiviral drugs to treat Hepatitis C and HIV.

64.   Developing drugs is a risky business, rife with failure.

65.   Developing drugs is expensive.

66.   Developing drugs remains a huge uncovered expense for the industry.

67.   Each has probably spent a few hundred million dollars developing their drug, and one may find itself shut out of the US market for years.

68.   Efforts are underway to develop drugs similar to naltrexone that work on different sites in the brain, Litten said.

69.   Expectations that Rilutek would be the first ALS drug to gain approval pushed stock prices lower at companies developing rival drugs, analysts said.

70.   --Extend a tax credit that encourages U.S. companies, including Genentech Inc., to develop drugs to treat rare diseases and disorders.